See all members

Louis Gendron

Ph.D. (doctor),  Regular member
Principal Interest
Rx (cannabis, opioids, ionic channels)
Secondary Interest
Primary Affiliation

Université de Sherbrooke

Secondary Affiliation
Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CHUS)

Subscription date
8 April 2020


Louis Gendron is a professor at the University of Sherbrooke and director of the pharmacology-physiology department. In addition to leading the inflammation-pain axis of CRCHUS, he is Editor-in-Chief of the renowned journal Progress in Neuro-Psychopharmacology & Biological Psychiatry (PNPBP). His main research interests are in the pharmacology of opioids. His laboratory notably combines approaches ranging from in vitro pharmacology to the study of behavior in order to better understand and then improve the therapeutic potential associated with the activation of the opioid delta receptor.